AllAnalyst Report
logoArgusFebruary 17, 2021

IQVIA Holdings Inc.: Raising target to $220

Symbols
IQV
Sector(s)
Healthcare
Rating
Current Price
Price Target
Earnings Estimate
Summary

IQVIA Holdings is the world's largest provider of biopharmaceutical development services and commercial outsourcing services. The company manages the largest contract research organization (CRO) in the world, with a focus on Phase II, III, and IV clinical trials and related analysis. It also provides contract sales representation, consulting research, and other healthcare services. The Durham, North Carolina-based company was founded in 1982 and went public in May 2013. In October 2016, Quintiles merged with IMS, a pharmaceutical data provider; a little over a year later it took the new name IQVIA. The merger has enabled it to integrate historical data

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level

Analyst Profile

Jasper Hellweg

Associate Analyst: Growth Pharmaceutical, Medical Technology & Financial Technology
At Argus Research, Jasper covers the Growth Pharmaceutical, Medical Technology, and Financial Technology companies. He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing. Prior to joining Argus, Jasper worked in a variety of industries, ranging from investment tradeshow management to musical instrument manufacturing. He started his career at Argus in the Research department and has since widened his scope to also include becoming a regular contributor for the Market Movers and Market Digest publications, the Vickers Weekly Insider Report and Argus' bespoke research on IPOs.